Wound Care Market Analysis

  • Report ID: 4823
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Wound Care Market Segmentation:

Functions Segment Analysis

The hospitals segment is set to have a substantial market share of 35% in 2035. This can be accredited to the large number of patients requiring advanced wound care and hospitalized for surgery or treatment of chronic conditions such as diabetes and pressure ulcers. The hospital also has the wound care management devices and staff necessary for advanced wound care, including growth factor therapy and negative pressure wound therapy (NPWT).

Applications Segment Analysis

In the year 2035, the chronic wounds segment in the wound care market is predicted to command a large proportion of over 60%. The segment's expansion can be attributed to the rising prevalence of chronic wounds such as diabetes, pressure ulcers, and other disorders. In the year 2018, the incidence of chronic ulcers was over 2 per 1000 population and the incidence of chronic leg ulcers was 1 per 1000 population. Chronic wounds can be defined as physiologically compromised wounds resulting from disruption of the wound healing cycle as a result of impaired angiogenesis, innervation, or cell migration, among others. Normal wound healing is discussed separately. Skin wounds that do not heal, heal slowly, or heal but tend to recur are called chronic wounds. Many causes of chronic (permanent) skin wounds may include trauma, burns, skin cancer, infections, or underlying conditions such as diabetes. Wounds that take a long time to heal require special care.

Our in-depth analysis of the global market includes the following segments:

         Functions

  • Hospitals
  • Specialty Clinics
  • Home Healthcare

         Applications

  • Chronic Wounds
  • Acute Wounds

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of wound care is evaluated at USD 23.16 billion.

The global wound care market size exceeded USD 21.99 billion in 2025 and is set to register a CAGR of more than 5.9%, exceeding USD 39.01 billion revenue by 2035.

North America wound care market will hold over 35% share by 2035, robust medical infrastructure and increase in surgical procedures.

Key players in the market include Arch Therapeutics, Inc., Convatec Group PLC, 3M Healthcare, Convatec Group PLC, Coloplast A/S, Cardinal Health, B. Braun Melsungen AG, Acelity L.P. Inc., Integra Lifesciences Holdings Corporation, Medtronic plc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos